Astra Zeneca har ingått ett exklusivt globalt licensavtal med Dizal Pharmaceutical för sin lungcancermedicin Zegfrovy (sunvozertinib), en oral EGFR-hämmare. #AstraZeneca #lungcancer #EGFRhæmmare

Astra Zeneca har ingått ett exklusivt globalt licensavtal med Dizal Pharmaceutical för sin lungcancermedicin Zegfrovy (sunvozertinib), en oral EGFR-hämmare. #AstraZeneca #lungcancer #EGFRhæmmare

Västra Götalandsregionen inför nya läkemedel och metoder för cancerbehandling och sällsynta sjukdomar, inklusive behandlingar för livmoderhalscancer och lungcancer, samt gentester för att optimera patientvården, med fokus på att förbättra kvalitet och patientsäkerhet. #VästraGötalandsregionen #cancerbehandling #sällsyntasjukdomar

Robert Berry, en snickare, upptäckte oväntat lungcancer under en årlig hälsokontroll vid Sophiahemmet 2016, vilket tack vare tidig diagnos gjorde att han kunde opereras framgångsrikt och nu är cancerfri, vilket han tillskriver betydelsen av regelbundna hälsokontroller. #Hälsokontroll #Cancer #Sjukvård

A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as late diagnoses, access issues, stigma, and a lack of oncologist consultations, despite the availability of promising new therapies that have significantly improved treatment outcomes for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US #CO #TX

A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, such as chemotherapy and immunotherapy, due to barriers like late diagnosis, access issues, shame, and fatalism, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US

A study published in JAMA Oncology reveals that more than half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as diagnostic delays, lack of access to oncologists, and social stigma, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US

A recent study revealed that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, highlighting barriers such as access, stigma, and diagnostic delays, despite significant advancements in drug options that have made the disease more treatable. #LungCancer #CancerTreatment #HealthEquity #US #TX

A recent study revealed that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, highlighting barriers such as access, stigma, and diagnostic delays, despite significant advancements in drug options that have made the disease more treatable. #LungCancer #CancerTreatment #HealthEquity #US #TX

A recent study published in JAMA Oncology revealed that over half of patients with metastatic lung cancer, despite the availability of new, effective treatments, do not receive life-extending therapies due to various barriers such as access issues, late diagnoses, stigma, and lack of oncologist consultations, highlighting a significant gap in care for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US

A recent study highlights that despite advancements in treatments for metastatic lung cancer, over half of patients do not receive life-extending therapies due to various barriers such as access issues, misconceptions about the disease, and the stigma associated with smoking, emphasizing the need for improved patient access to oncologists and education about available treatments. #LungCancer #CancerTreatment #HealthCareAccess #US

A recent study highlights that despite advancements in treatments for metastatic lung cancer, over half of patients do not receive life-extending therapies due to various barriers such as access issues, misconceptions about the disease, and the stigma associated with smoking, emphasizing the need for improved patient access to oncologists and education about available treatments. #LungCancer #CancerTreatment #HealthCareAccess #US
Fumar es un grave problema de salud pública que causa más de 8 millones de muertes anuales y está directamente relacionado con el cáncer de pulmón, según el cirujano torácico Diego González Rivas, quien enfatiza la necesidad de un enfoque radical para motivar a los pacientes a dejar el tabaco antes de que sea demasiado tarde. #TobaccoAwareness #LungCancer #PublicHealth

Un estudio reciente revela un aumento preocupante de cáncer de pulmón en mujeres jóvenes no fumadoras, vinculando potencialmente esta tendencia a factores como pesticidas y el uso de anticonceptivos orales, aunque los investigadores advierten que se necesita más investigación para entender estas asociaciones y que una alimentación saludable sigue siendo crucial para la salud general. #LungCancer #EnvironmentalHealth #NutritionImpact

El doctor Diego González Rivas advierte sobre la gravedad del cáncer de pulmón, una enfermedad que a menudo no presenta síntomas hasta etapas avanzadas, y destaca la importancia de dejar de fumar radicalmente para prevenir su alto índice de mortalidad, que podría alcanzar 2,3 millones de muertes anuales globalmente para 2030 si no se implementan medidas adecuadas. #LungCancer #HealthAwareness #SmokingCessation

A study published by the USC Norris Comprehensive Cancer Center suggests that a healthy diet, particularly rich in fruits, vegetables, and whole grains, may be linked to a higher risk of lung cancer in non-smoking Americans under 50, potentially due to pesticide exposure rather than the foods themselves. #LungCancer #HealthyEating #PesticideExposure
